|
|
Breast Cancer Trial Results
1. Radiation Therapy Helps Prevent DCIS Recurrence After Breast-Conserving Surgery (Posted: 03/10/2009) - The addition of radiation therapy to breast-conserving surgery halves the risk of a tumor recurrence compared with surgery alone in women with noninvasive breast tumors, according to a pooled analysis of trial results published January 21, 2009, by the Cochrane Reviews.
2. Removal of Ovaries and Fallopian Tubes Cuts Cancer Risk for BRCA1/2 Carriers (Posted: 02/24/2009) - Surgery that removes the ovaries and fallopian tubes is one of the most effective ways to decrease a woman's risk of breast and gynecologic cancer if she carries a BRCA1 or BRCA2 gene mutation, according to the Jan. 21, 2009, Journal of the National Cancer Institute.
3. Shorter Course of Radiation Might Be Just as Effective with Early Breast Cancer (Posted: 05/23/2000, Updated: 10/14/2008) - For some women with early breast cancer, a shorter, more intense course of radiation therapy after surgery may be just as effective as the standard longer course, according to updated results presented at the 2008 annual meeting of the American Society for Therapeutic Radiation and Oncology.
4. Denosumab May Help Prevent Bone Loss Related to Use of Aromatase Inhibitors (Posted: 09/11/2008) - Treatment with the experimental drug denosumab increased bone density in postmenopausal women taking aromatase inhibitors to prevent a recurrence of breast cancer, according to a report published online August 25, 2008, by the Journal of Clinical Oncology.
5. Osteoporosis Drug Raloxifene Does Not Protect Against Coronary Heart Disease, But Reduces Breast Cancer Risk (Posted: 08/28/2006, Updated: 07/17/2008) - The drug raloxifene (Evista®) did not prevent heart problems in postmenopausal women with, or at high risk for, coronary heart disease, according to the July 13, 2006, issue of the New England Journal of Medicine.
1 2 3 4 Next > |
|
|